Navigation Links
T-cells Developed from Human Embryonic Stem Cells

Researchers have found for the first time that human embryonic stem cells can be genetically manipulated and coaxed to develop into mature T-cells//, raising hopes for a gene therapy to combat AIDS.

Researchers from the UCLA AIDS Institute and the Institute for Stem Cell Biology and Medicine have found that it is possible to convert human embryonic stem cells into blood-forming stem cells that in turn can differentiate into the helper T-cells that HIV specifically targets. T-cells are one of the body’s main defenses against disease.

The results mark the first time that scientists have been able to derive T-cells out of human embryonic stem cells, said Zoran Galic, assistant research biologist, and lead researcher on the study.

“This tells you that you may be able to use human embryonic stem cells to treat T cell and other blood diseases. This could be a very important weapon in the fight against AIDS,” Galic said.

The study is available at http://www.pnas.org/papbyrecent.shtml.

In their study, the researchers cultured human embryonic stem cells, which were incubated on mouse bone marrow support cells, which in turn converted them into blood forming cells. Those cells were then injected into a human thymus gland that had been implanted in a mouse, and the thymus then changed those blood-forming cells into T-cells. Located just above the heart in humans, the thymus is the organ where T-cells develop. It gradually shrinks in adults, weakening the immune system over time.

These results indicate that it is possible to decipher the signals that control the development of embryonic stem cells into mature T-cells, said study co-author Jerome Zack, associate director of the UCLA AIDS Institute, and professor of medicine and of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA.

“That way we can eventually repopulate the immune system in patients need ing T-cells,” Zack said.

This in turn could give rise to gene therapy approaches to treat other diseases involving T-cells. In addition to HIV, for instance, the technique could be used to treat severe combined immunodeficiency, or the “bubble boy disease,” which leaves its victims without a working immune system, forcing them to a life in an antiseptic, germ-free environment.

(Source: Newsise)
'"/>




Related medicine news :

1. Regulatory T-cells – Protector or Cause of Diseases
2. Scientists Developed Map For Brain Molecular Communities
3. Scientists Developed Cheap Way To Assess Sleep
4. Diabetic Friendly Egg Developed In India
5. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
6. Cervical Cancer Vaccine To Be Developed In India
7. Anti-Microbial Coating For Use Over Biomedical Devices Developed
8. Cure for Osteoarthritis To Be Developed
9. Mice With Human Thought Processes Could Be Developed In The Future
10. Viagra Pill For Women To Be Developed
11. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: